Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - COST OF REVENUE
Cost of Revenue CRVS - Corvus Pharmaceuticals, Inc.
151 K
LAST VALUE
-42.71%
2 YEAR CAGR
-29.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR